Embecta Corp (EMBC)

Currency in USD
10.32
+0.04(+0.39%)
Closed·
10.59+0.27(+2.57%)
·
High dividend Yield
EMBC is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
10.1010.52
52 wk Range
9.2015.55
Key Statistics
Prev. Close
10.32
Open
10.34
Day's Range
10.1-10.52
52 wk Range
9.2-15.55
Volume
686.95K
Average Volume (3m)
773.62K
1-Year Change
-25.8621%
Book Value / Share
-10.35
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EMBC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
16.67
Upside
+61.50%
Members' Sentiments
Bearish
Bullish
ProTips
Pays a significant dividend to shareholders

Embecta Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Embecta Company Profile

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Embecta Corp Earnings Call Summary for Q1/2026

  • Embecta Corp. exceeded Q1 2026 forecasts with EPS of $0.71 vs $0.67 expected and revenue of $261M vs $258.07M expected, driving a 4.85% pre-market stock increase to $11.90.
  • Despite a slight 0.3% YoY revenue decline, the company maintained a strong gross profit of $161.7M with a 61.9% margin and generated $17M in free cash flow.
  • CEO Dev Kurdikar emphasized strengthening core business while expanding into the GLP-1 market, which the company projects could generate $100M+ by 2033.
  • Embecta reaffirmed full-year guidance with revenue between $1.071B-$1.093B, adjusted EPS of $2.80-$3.00, and plans to repay approximately $150M in debt during 2026.
  • Key challenges include U.S. pricing pressures, macroeconomic headwinds in international markets, increased GLP-1 competition, and potential supply chain disruptions.
Last Updated: 05/02/2026, 13:52
Read Full Transcript

Compare EMBC to Peers and Sector

Metrics to compare
EMBC
Peers
Sector
Relationship
P/E Ratio
4.4x13.5x−0.6x
PEG Ratio
0.030.290.00
Price/Book
−1.0x3.4x2.6x
Price / LTM Sales
0.6x2.7x3.3x
Upside (Analyst Target)
35.7%43.3%44.5%
Fair Value Upside
Unlock14.1%5.0%Unlock

Analyst Ratings

1 Buy
2 Hold
1 Sell
Ratings:
4 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 16.67
(+61.50% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BTIG
Buy25.00+142.25%-Maintain25/11/2025
BTIG
Buy25.00+142.25%-Maintain19/09/2025
Mizuho
Hold14.00+35.66%12.00Maintain11/08/2025
Mizuho
Hold12.00+16.28%13.00Maintain15/07/2025
BofA Securities
Sell18.00+74.42%20.00Maintain29/05/2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.36%
Dividend Yield
5.81%
Industry Median 1.34%
Annualised payout
0.60
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 05, 2026
EPS / Forecast
0.71 / 0.67
Revenue / Forecast
261.20M / 258.07M
EPS Revisions
Last 90 days

People Also Watch

1.46
CSTE
-5.19%
8.900
INNV
-0.22%
5.00
ACDC
-2.72%
13.64
VREX
+1.26%

FAQ

What Is the Embecta (EMBC) Share Price Today?

The Embecta stock price today is 10.32 USD.

What Stock Exchange Does Embecta (EMBC) Trade On?

Embecta is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Embecta?

The stock symbol (also called a 'ticker') for Embecta is "EMBC."

Does Embecta Pay Dividends? What’s The Current EMBC Dividend Yield?

Yes, EMBC Pays Dividends to its Shareholders. The current Embecta dividend yield is 5.81%.

What Is the Current Embecta Market Cap?

As of today, Embecta market cap is 611.15M USD.

What Is Embecta's (EMBC) Earnings Per Share (TTM)?

The Embecta EPS is currently 2.36 (Trailing Twelve Months).

When Is the Next Embecta Earnings Date?

Embecta's next earnings report will be released on 08/05/2026.

Is EMBC a Buy or Sell From a Technical Analyst Perspective?

Based on today's Embecta moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Embecta Stock Split?

Embecta has split 0 times. (See the EMBC stock split history page for full effective split date and price information.)

How Many Employees Does Embecta Have?

Embecta has 1850 employees.

What is the current trading status of Embecta (EMBC)?

As of 26/02/2026, Embecta (EMBC) is trading at a price of 10.32 USD, with a previous close of 10.32 USD. The stock has fluctuated within a day range of 10.10 USD to 10.52 USD, while its 52-week range spans from 9.20 USD to 15.55 USD.

What Is Embecta (EMBC) Price Target According to Analysts?

The average 12-month price target for Embecta is 16.67 USD, with a high estimate of 25 USD and a low estimate of 11 USD. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +61.50% Upside potential.

What Is the EMBC After Hours Price?

EMBC's last after hours stock price is 10.59 USD, the stock has decreased by 0.27, or 2.57%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.